Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Nasus Pharma Ltd. ( (NSRX) ) has provided an update.
On November 3, 2025, Nasus Pharma Ltd. released an updated corporate presentation on its website. The presentation, however, is not intended as a prospectus or an offer to sell or purchase securities, indicating it is primarily informational rather than promotional. This update may provide stakeholders with insights into the company’s current strategies or developments, although it does not directly impact the company’s market operations or stakeholder commitments.
The most recent analyst rating on (NSRX) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on Nasus Pharma Ltd. stock, see the NSRX Stock Forecast page.
More about Nasus Pharma Ltd.
Average Trading Volume: 35,007
See more data about NSRX stock on TipRanks’ Stock Analysis page.